tiprankstipranks
Trending News
More News >
Yakult Honsha Co (JP:2267)
OTHER OTC:2267

Yakult Honsha Co (2267) AI Stock Analysis

Compare
4 Followers

Top Page

JP:2267

Yakult Honsha Co

(OTC:2267)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
¥2,618.00
▲(8.99% Upside)
Yakult Honsha Co's strong financial performance is the most significant factor, supported by solid profitability and balance sheet metrics. However, technical analysis indicates a bearish trend, which could impact short-term performance. The valuation is fair, providing a balanced outlook for investors.
Positive Factors
Strong Profitability
Consistent profitability margins indicate effective cost management and pricing power, supporting long-term financial stability and growth potential.
Robust Balance Sheet
A strong balance sheet with low leverage enhances financial flexibility, allowing the company to invest in growth opportunities and withstand economic downturns.
Efficient Cash Generation
Efficient cash generation supports ongoing operations, debt repayment, and future investments, ensuring long-term sustainability and shareholder value.
Negative Factors
Revenue Decline
Declining revenue poses challenges for future growth, potentially impacting the company's ability to expand market share and invest in new initiatives.
Earnings Decline
A decline in earnings per share indicates potential profitability challenges, which could affect investor confidence and limit reinvestment capabilities.
Revenue Growth Challenges
Negative revenue growth highlights difficulties in expanding sales, which may hinder the company's ability to capture new markets and sustain competitive advantage.

Yakult Honsha Co (2267) vs. iShares MSCI Japan ETF (EWJ)

Yakult Honsha Co Business Overview & Revenue Model

Company DescriptionYakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as generic anti-cancer agents, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. In addition, the company offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyYakult Honsha generates revenue primarily through the sale of its probiotic beverages and dairy products. The company's main revenue streams come from direct sales to consumers through its extensive distribution network, which includes supermarkets, convenience stores, and direct home delivery services. Additionally, Yakult has established partnerships with various retailers and health organizations to enhance its market reach. The company also benefits from international sales, expanding its footprint in various countries, which contributes significantly to its revenue. Furthermore, Yakult invests in research and development to innovate and introduce new products, thereby attracting more customers and increasing sales. The strong brand recognition and consumer trust in its health benefits further solidify its earnings.

Yakult Honsha Co Financial Statement Overview

Summary
Yakult Honsha Co presents a strong financial profile with high profitability margins and solid balance sheet metrics. The company exhibits prudent financial management with efficient operational cash flows. However, recent revenue decline could pose challenges for future growth.
Income Statement
78
Positive
Yakult Honsha Co demonstrates strong profitability with a consistent Gross Profit Margin and Net Profit Margin. However, there is a slight decrease in revenue observed in the most recent year compared to the previous year, indicating challenges in top-line growth. The EBIT and EBITDA margins are healthy, showing efficient operational management.
Balance Sheet
83
Very Positive
The balance sheet reflects a robust financial position with a low Debt-to-Equity ratio, indicating moderate leverage. The company maintains a strong Equity Ratio, suggesting financial stability and a solid asset base. Return on Equity is impressive, reflecting effective utilization of shareholder funds.
Cash Flow
75
Positive
Yakult Honsha Co shows steady operating cash flow with a healthy Free Cash Flow, although there is a decline from the previous year. The Operating Cash Flow to Net Income Ratio indicates efficient cash generation from operations. The Free Cash Flow to Net Income Ratio remains strong, supporting future investments and debt repayment.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue493.63B499.68B503.08B483.07B415.12B385.71B
Gross Profit290.45B295.52B299.91B288.48B248.42B226.82B
EBITDA86.96B111.19B108.87B104.53B93.93B82.21B
Net Income43.04B45.53B51.01B50.64B44.92B39.27B
Balance Sheet
Total Assets832.52B864.32B833.29B749.42B672.86B635.10B
Cash, Cash Equivalents and Short-Term Investments237.60B269.06B255.26B241.19B202.94B176.25B
Total Debt97.93B108.10B96.53B77.14B82.94B99.25B
Total Liabilities233.14B234.80B227.34B203.93B187.92B195.34B
Stockholders Equity545.61B574.13B549.28B498.66B446.07B404.95B
Cash Flow
Free Cash Flow0.0031.00B24.47B56.23B46.66B32.16B
Operating Cash Flow0.0084.69B70.70B86.51B73.39B55.82B
Investing Cash Flow0.00-61.02B-43.91B-19.02B-11.88B-19.62B
Financing Cash Flow0.00-31.47B-39.54B-44.53B-45.16B-31.25B

Yakult Honsha Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2402.00
Price Trends
50DMA
2432.06
Positive
100DMA
2423.63
Positive
200DMA
2628.15
Negative
Market Momentum
MACD
-9.67
Negative
RSI
51.37
Neutral
STOCH
90.24
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2267, the sentiment is Positive. The current price of 2402 is below the 20-day moving average (MA) of 2430.35, below the 50-day MA of 2432.06, and below the 200-day MA of 2628.15, indicating a neutral trend. The MACD of -9.67 indicates Negative momentum. The RSI at 51.37 is Neutral, neither overbought nor oversold. The STOCH value of 90.24 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2267.

Yakult Honsha Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥939.59B20.415.97%3.00%2.79%-6.46%
72
Outperform
¥39.12B21.421.36%14.83%12.35%
69
Neutral
¥220.16B13.292.50%0.32%-20.60%
68
Neutral
¥774.25B17.087.18%2.66%-3.87%-16.49%
65
Neutral
¥333.62B29.842.39%2.33%-8.76%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
¥24.22B24.461.61%-1.14%3.35%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2267
Yakult Honsha Co
2,421.00
-521.47
-17.72%
JP:2269
Meiji Holdings Co
3,392.00
347.77
11.42%
JP:2264
Morinaga Milk Industry Co., Ltd.
3,695.00
907.22
32.54%
JP:2266
Rokko Butter Co., Ltd.
1,245.00
-100.46
-7.47%
JP:2268
BR 31 Ice Cream Co., Ltd.
4,055.00
19.16
0.47%
JP:2270
MEGMILK SNOW BRAND Co., Ltd.
3,205.00
579.63
22.08%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 03, 2025